Page last updated: 2024-12-05

n-methylbenzamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-methylbenzamide is a simple amide derivative of benzoic acid. Its synthesis is typically achieved by reacting benzoyl chloride with methylamine. N-methylbenzamide has been investigated for its potential biological activities, including anti-inflammatory and analgesic properties. It has also been used as a starting material in the synthesis of various pharmaceuticals and agrochemicals. Researchers study N-methylbenzamide to explore its structure-activity relationships and to develop new compounds with enhanced therapeutic properties. Its potential applications in medicinal chemistry and organic synthesis continue to drive ongoing research.'

N-methylbenzamide: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11954
CHEMBL ID275261
SCHEMBL ID7551593
SCHEMBL ID6100
SCHEMBL ID9580804
MeSH IDM0115904

Synonyms (50)

Synonym
wln: 1mvr
n-methylbenzenamide
nsc-42944
benzamide, n-methyl-
613-93-4
nsc42944
n-methylbenzamide
NCGC00091232-01
AP-065/40250235
einecs 210-362-3
ai3-01069
n-methylbenzenecarboxamide
brn 1209880
nsc 42944
ccris 4670
n-methylbenzamide, >=99%
n-methyl-benzamide
CHEMBL275261
nccharwockohih-uhfffaoysa-
inchi=1/c8h9no/c1-9-8(10)7-5-3-2-4-6-7/h2-6h,1h3,(h,9,10)
AKOS002304094
A833200
NCGC00091232-02
cas-613-93-4
dtxsid5025570 ,
NCGC00257774-01
tox21_200220
dtxcid605570
SCHEMBL7551593
88070-48-8
k3ed781e08 ,
unii-k3ed781e08
FT-0632559
methylbenzamide, n-
SCHEMBL6100
n-methyl benzamide
Z32016410
SCHEMBL9580804
W-109573
mfcd00011642
benzenecarboximidic acid,n-methyl-
SY037937
HY-135848
F16588
AS-11419
EN300-131692
Q27281901
CS-0114596
12-dimethyl-3-propylimidazoliumtris(tri
n-methylbenzamid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency0.44670.003245.467312,589.2998AID2517
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency0.004419.739145.978464.9432AID1159509
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency30.19400.000627.21521,122.0200AID743202; AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID122378Antitumor activity was evaluated for the compound against the M5076 reticulum cell sarcoma in mice and the % T/C(treated/control) value was calculated at optimal dose of 400 mg/kg1986Journal of medicinal chemistry, Jun, Volume: 29, Issue:6
Structural studies on bioactive compounds. 4. A structure-antitumor activity study on analogues of N-methylformamide.
AID70688Percentage of benzidine-positive murine erythroleukemia cells on day 6.1981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Induction of differentiation of leukemia cells in vitro by N-substituted amides, lactams, and 2-pyridones.
AID70691Concentration producing the maximum percentage of benzidine-positive cells after 6-days of continuous exposure in murine leukemia cells.1981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Induction of differentiation of leukemia cells in vitro by N-substituted amides, lactams, and 2-pyridones.
AID116706Antitumor activity was evaluated against the M5076 reticulum cell sarcoma in mice at dose of 800-100 mg/kg per day1986Journal of medicinal chemistry, Jun, Volume: 29, Issue:6
Structural studies on bioactive compounds. 4. A structure-antitumor activity study on analogues of N-methylformamide.
AID110149Antitumor activity was evaluated against the M5076 reticulum cell sarcoma in mice measured as Control tumor volume for the treated at the optimal dose 400 mg/Kg day1986Journal of medicinal chemistry, Jun, Volume: 29, Issue:6
Structural studies on bioactive compounds. 4. A structure-antitumor activity study on analogues of N-methylformamide.
AID118809Antitumor activity was evaluated against the M5076 reticulum cell sarcoma in mice measured as mean tumor volume for the treated at the optimal dose 400 mg/kg day1986Journal of medicinal chemistry, Jun, Volume: 29, Issue:6
Structural studies on bioactive compounds. 4. A structure-antitumor activity study on analogues of N-methylformamide.
AID116890Antitumor activity was evaluated against the M5076 reticulum cell sarcoma in mice at dose of 800-100 mg/kg per day1986Journal of medicinal chemistry, Jun, Volume: 29, Issue:6
Structural studies on bioactive compounds. 4. A structure-antitumor activity study on analogues of N-methylformamide.
AID70689Cell growth was measured on day 3, after murine erythroleukemia cells were exposed at a cell concentration of 1*10e5 cells/mL.1981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Induction of differentiation of leukemia cells in vitro by N-substituted amides, lactams, and 2-pyridones.
AID70690Cell growth was measured on day 6 after murine erythroleukemia cells were exposed at a cell concentration of 1*10e5 cells/mL.1981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Induction of differentiation of leukemia cells in vitro by N-substituted amides, lactams, and 2-pyridones.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (30.77)18.7374
1990's1 (7.69)18.2507
2000's3 (23.08)29.6817
2010's4 (30.77)24.3611
2020's1 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.61

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.61 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index67.98 (26.88)
Search Engine Supply Index2.03 (0.95)

This Compound (46.61)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]